A2Z Infra Engineering Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 18, 2025, 9:57 pm

Competitors of A2Z Infra Engineering Ltd

All Competitor Stocks of A2Z Infra Engineering Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:30 pm

Below is a detailed analysis of the quarterly data for A2Z Infra Engineering Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 90.51 Cr.. The value appears to be declining and may need further review. It has decreased from 90.66 Cr. (Mar 2025) to 90.51 Cr., marking a decrease of 0.15 Cr..
• For Expenses, as of Jun 2025, the value is 83.75 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 81.56 Cr. (Mar 2025) to 83.75 Cr., marking an increase of 2.19 Cr..
• For Operating Profit, as of Jun 2025, the value is 6.76 Cr.. The value appears to be declining and may need further review. It has decreased from 9.10 Cr. (Mar 2025) to 6.76 Cr., marking a decrease of 2.34 Cr..
• For OPM %, as of Jun 2025, the value is 7.47%. The value appears to be declining and may need further review. It has decreased from 10.04% (Mar 2025) to 7.47%, marking a decrease of 2.57%.
• For Other Income, as of Jun 2025, the value is -2.48 Cr.. The value appears to be declining and may need further review. It has decreased from 1.71 Cr. (Mar 2025) to -2.48 Cr., marking a decrease of 4.19 Cr..
• For Interest, as of Jun 2025, the value is 1.45 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.25 Cr. (Mar 2025) to 1.45 Cr., marking a decrease of 0.80 Cr..
• For Depreciation, as of Jun 2025, the value is 1.26 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.25 Cr. (Mar 2025) to 1.26 Cr., marking an increase of 0.01 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.57 Cr.. The value appears to be declining and may need further review. It has decreased from 7.31 Cr. (Mar 2025) to 1.57 Cr., marking a decrease of 5.74 Cr..
• For Tax %, as of Jun 2025, the value is 63.69%. The value appears to be improving (decreasing) as expected. It has decreased from 82.49% (Mar 2025) to 63.69%, marking a decrease of 18.80%.
• For Net Profit, as of Jun 2025, the value is 0.57 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Mar 2025) to 0.57 Cr., marking a decrease of 0.69 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.04. The value appears to be declining and may need further review. It has decreased from 0.23 (Mar 2025) to 0.04, marking a decrease of 0.19.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 22, 2025, 4:17 pm

Growth

Last Updated: September 4, 2025, 9:55 pm

Balance Sheet

Last Updated: June 16, 2025, 12:34 pm

Below is a detailed analysis of the balance sheet data for A2Z Infra Engineering Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 176.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 176.00 Cr..
• For Reserves, as of Mar 2025, the value is -131.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -144.00 Cr. (Mar 2024) to -131.00 Cr., marking an improvement of 13.00 Cr..
• For Borrowings, as of Mar 2025, the value is 92.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 198.00 Cr. (Mar 2024) to 92.00 Cr., marking a decrease of 106.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 362.00 Cr.. The value appears to be improving (decreasing). It has decreased from 453.00 Cr. (Mar 2024) to 362.00 Cr., marking a decrease of 91.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 498.00 Cr.. The value appears to be improving (decreasing). It has decreased from 683.00 Cr. (Mar 2024) to 498.00 Cr., marking a decrease of 185.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 73.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2024) to 73.00 Cr., marking a decrease of 2.00 Cr..
• For CWIP, as of Mar 2025, the value is 18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Mar 2024) to 18.00 Cr., marking a decrease of 40.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 36.00 Cr..
• For Other Assets, as of Mar 2025, the value is 408.00 Cr.. The value appears to be declining and may need further review. It has decreased from 514.00 Cr. (Mar 2024) to 408.00 Cr., marking a decrease of 106.00 Cr..
• For Total Assets, as of Mar 2025, the value is 498.00 Cr.. The value appears to be declining and may need further review. It has decreased from 683.00 Cr. (Mar 2024) to 498.00 Cr., marking a decrease of 185.00 Cr..

However, the Borrowings (92.00 Cr.) are higher than the Reserves (-131.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for A2Z Infra Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 5. It has increased from -0.32 (Mar 24) to 0.51, marking an increase of 0.83.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 5. It has increased from -0.32 (Mar 24) to 0.51, marking an increase of 0.83.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.45. This value is below the healthy minimum of 3. It has decreased from 1.82 (Mar 24) to 0.45, marking a decrease of 1.37.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2.56. It has increased from 1.56 (Mar 24) to 2.56, marking an increase of 1.00.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2.56. It has increased from 1.56 (Mar 24) to 2.56, marking an increase of 1.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 19.09. It has decreased from 22.06 (Mar 24) to 19.09, marking a decrease of 2.97.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.72. This value is below the healthy minimum of 2. It has increased from -0.94 (Mar 24) to 1.72, marking an increase of 2.66.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.44. This value is within the healthy range. It has increased from -1.24 (Mar 24) to 1.44, marking an increase of 2.68.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.68. This value is within the healthy range. It has decreased from 1.68 (Mar 24) to 0.68, marking a decrease of 1.00.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.17. This value is below the healthy minimum of 2. It has decreased from 1.52 (Mar 24) to 0.17, marking a decrease of 1.35.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 2. It has increased from -0.32 (Mar 24) to 0.50, marking an increase of 0.82.
• For PBDIT Margin (%), as of Mar 25, the value is 8.99. This value is below the healthy minimum of 10. It has increased from -4.27 (Mar 24) to 8.99, marking an increase of 13.26.
• For PBIT Margin (%), as of Mar 25, the value is 7.52. This value is below the healthy minimum of 10. It has increased from -5.60 (Mar 24) to 7.52, marking an increase of 13.12.
• For PBT Margin (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 10. It has decreased from 7.62 (Mar 24) to 3.57, marking a decrease of 4.05.
• For Net Profit Margin (%), as of Mar 25, the value is 0.89. This value is below the healthy minimum of 5. It has decreased from 6.91 (Mar 24) to 0.89, marking a decrease of 6.02.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.66. This value is below the healthy minimum of 8. It has increased from -1.46 (Mar 24) to 2.66, marking an increase of 4.12.
• For Return on Networth / Equity (%), as of Mar 25, the value is 19.86. This value is within the healthy range. It has increased from -20.67 (Mar 24) to 19.86, marking an increase of 40.53.
• For Return on Capital Employeed (%), as of Mar 25, the value is 35.15. This value is within the healthy range. It has increased from -27.35 (Mar 24) to 35.15, marking an increase of 62.50.
• For Return On Assets (%), as of Mar 25, the value is 1.80. This value is below the healthy minimum of 5. It has increased from -0.83 (Mar 24) to 1.80, marking an increase of 2.63.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 2.03. This value exceeds the healthy maximum of 1. It has decreased from 7.18 (Mar 24) to 2.03, marking a decrease of 5.15.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.56. It has increased from 0.46 (Mar 24) to 0.56, marking an increase of 0.10.
• For Current Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1.5. It has increased from 0.72 (Mar 24) to 0.77, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 0.77. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.77, marking an increase of 0.05.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.80. This value is within the healthy range. It has increased from -2.67 (Mar 24) to 3.80, marking an increase of 6.47.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.05. This value is below the healthy minimum of 3. It has increased from -3.94 (Mar 24) to 2.05, marking an increase of 5.99.
• For Enterprise Value (Cr.), as of Mar 25, the value is 308.03. It has decreased from 420.11 (Mar 24) to 308.03, marking a decrease of 112.08.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.08 (Mar 24) to 0.91, marking a decrease of 0.17.
• For EV / EBITDA (X), as of Mar 25, the value is 10.18. This value is within the healthy range. It has increased from -25.31 (Mar 24) to 10.18, marking an increase of 35.49.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 24) to 0.71, marking an increase of 0.11.
• For Price / BV (X), as of Mar 25, the value is 5.32. This value exceeds the healthy maximum of 3. It has decreased from 8.60 (Mar 24) to 5.32, marking a decrease of 3.28.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 24) to 0.71, marking an increase of 0.11.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.02 (Mar 24) to 0.03, marking an increase of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness